Lung Cancer

Alectinib Found Active in Advanced ALK-Positive Advanced NSCLC Characterized by Crizotinib Resistance Mutations

By

Susan Moench, PhD, PA-C

Publish Date December 9, 2019

In this analysis, data from a pair of phase 2 studies of patients with ALK-positive, crizotinib-resistant advanced NSCLC were pooled.

Eosinophilic Fasciitis: A Rare Immune-Related Adverse Effect of Immune Checkpoint Inhibitor Therapy

By

Susan Moench, PhD, PA-C

Publish Date December 4, 2019

Diagnosis and management of EF in the setting of cancer immunotherapy requires close collaboration between patient’s oncologist, dermatologist, and rheumatologist.

Treatment Beneficial for Nonagenarians With Lung Cancer

Publish Date December 2, 2019

Most pronounced survival benefit seen for patients with stage I disease.

DCNN Software Aids Detection of Malignant Lung Nodules on CXR

Publish Date December 2, 2019

Use of software improves sensitivity of radiologists, reduces number of false-positive findings.

CDC: Approximately 20 Percent of U.S. Adults Currently Use Tobacco Products

Publish Date November 26, 2019

Prevalence of use higher for men, adults aged ≤65 years, uninsured, those with disability or limitation.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)